APrevent

APrevent

APrevent's products improve voice and communication, focusing on the development of a long- term implant system and speech conversion platform for patients with glottic insufficiency and dysarthria.

Launch date
Employees
Market cap
-
Enterprise valuation
€22—33m (Dealroom.co estimates May 2024.)
Company register number FN 432512y
Stadt Feldkirch Vorarlberg (HQ)
Authorizing premium user...